172 related articles for article (PubMed ID: 32603822)
1. The gastroprotective potential of silibinin against Helicobacter pylori infection and gastric tumor cells.
Bittencourt MLF; Rodrigues RP; Kitagawa RR; Gonçalves RCR
Life Sci; 2020 Sep; 256():117977. PubMed ID: 32603822
[TBL] [Abstract][Full Text] [Related]
2. Antitumour, Immunomodulatory activity and in silico studies of naphthopyranones targeting iNOS, a relevant target for the treatment of Helicobacter pylori infection.
Ardisson JS; Gonçalves RCR; Rodrigues RP; Kitagawa RR
Biomed Pharmacother; 2018 Nov; 107():1160-1165. PubMed ID: 30257329
[TBL] [Abstract][Full Text] [Related]
3. New frontiers in gut nutrient sensor research: prophylactic effect of glutamine against Helicobacter pylori-induced gastric diseases in Mongolian gerbils.
Amagase K; Nakamura E; Endo T; Hayashi S; Hasumura M; Uneyama H; Torii K; Takeuchi K
J Pharmacol Sci; 2010; 112(1):25-32. PubMed ID: 20093785
[TBL] [Abstract][Full Text] [Related]
4. Dietary prevention of Helicobacter pylori-associated gastric cancer with kimchi.
Jeong M; Park JM; Han YM; Park KY; Lee DH; Yoo JH; Cho JY; Hahm KB
Oncotarget; 2015 Oct; 6(30):29513-26. PubMed ID: 26317548
[TBL] [Abstract][Full Text] [Related]
5. Silibinin promotes the apoptosis of gastric cancer BGC823 cells through caspase pathway.
Li R; Yu J; Wang C
J BUON; 2017; 22(5):1148-1153. PubMed ID: 29135096
[TBL] [Abstract][Full Text] [Related]
6. Anti-Helicobacter pylori Activity of Isocoumarin Paepalantine: Morphological and Molecular Docking Analysis.
Damasceno JPL; Rodrigues RP; Gonçalves RCR; Kitagawa RR
Molecules; 2017 May; 22(5):. PubMed ID: 28498343
[TBL] [Abstract][Full Text] [Related]
7. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
[TBL] [Abstract][Full Text] [Related]
8. Bacterial-binding chitosan microspheres for gastric infection treatment and prevention.
Gonçalves IC; Magalhães A; Fernandes M; Rodrigues IV; Reis CA; Martins MC
Acta Biomater; 2013 Dec; 9(12):9370-8. PubMed ID: 23920152
[TBL] [Abstract][Full Text] [Related]
9. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection promotes Aquaporin 3 expression via the ROS-HIF-1α-AQP3-ROS loop in stomach mucosa: a potential novel mechanism for cancer pathogenesis.
Wen J; Wang Y; Gao C; Zhang G; You Q; Zhang W; Zhang Z; Wang S; Peng G; Shen L
Oncogene; 2018 Jun; 37(26):3549-3561. PubMed ID: 29563612
[TBL] [Abstract][Full Text] [Related]
11. High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells.
Kato S; Tsukamoto T; Mizoshita T; Tanaka H; Kumagai T; Ota H; Katsuyama T; Asaka M; Tatematsu M
Int J Cancer; 2006 Oct; 119(7):1558-66. PubMed ID: 16646055
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.
Shao L; Chen Z; Soutto M; Zhu S; Lu H; Romero-Gallo J; Peek R; Zhang S; El-Rifai W
FASEB J; 2019 Jan; 33(1):264-274. PubMed ID: 29985646
[TBL] [Abstract][Full Text] [Related]
13. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.
Sokic-Milutinovic A; Alempijevic T; Milosavljevic T
World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice.
De R; Sarkar A; Ghosh P; Ganguly M; Karmakar BC; Saha DR; Halder A; Chowdhury A; Mukhopadhyay AK
J Antimicrob Chemother; 2018 Jun; 73(6):1595-1603. PubMed ID: 29566160
[TBL] [Abstract][Full Text] [Related]
16. Plaunotol suppresses interleukin-8 secretion induced by Helicobacter pylori: therapeutic effect of plaunotol on H. pylori infection.
Takagi A; Koga Y; Aiba Y; Kabir AM; Watanabe S; Ohta-Tada U; Osaki T; Kamiya S; Miwa T
J Gastroenterol Hepatol; 2000 Apr; 15(4):374-80. PubMed ID: 10824880
[TBL] [Abstract][Full Text] [Related]
17. Review article: exploring the link between Helicobacter pylori and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1999 Mar; 13 Suppl 1():3-11. PubMed ID: 10209681
[TBL] [Abstract][Full Text] [Related]
18. Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori.
Zhang ZW; Abdullahi M; Farthing MJ
Gut; 2002 Feb; 50(2):165-9. PubMed ID: 11788554
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease.
Kim JS; Chung SJ; Choi YS; Cheon JH; Kim CW; Kim SG; Jung HC; Song IS
Br J Cancer; 2007 May; 96(9):1324-8. PubMed ID: 17406363
[TBL] [Abstract][Full Text] [Related]
20. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
